Oncogenic crosstalk between ErbB2, nucleolin and Ras
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Gal Zysman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Tel-Aviv University, Ramat-Aviv 69978, Israel. Hauptthemen laut MEDLINE: Phosphoproteins, RNA-Binding Proteins, Erb-b2 Receptor Tyrosine Kinases, ras Proteins. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Israel Cancer Association.
Abstract (Originalsprache)
Overexpression of ErbB receptors, their signaling components and expression of mutant Ras are major contributors to cancer development. Mutant Ras can affect ErbB receptors activation, and the nucleolar protein nucleolin (NCL) can bind and activate ErbB receptors. Previously it was also demonstrated that activated Ras could interact and enhance nucleolin and ErbB1 receptors interaction. Moreover, it was shown that this interaction enhances tumor cell growth. Since ErbB receptors are major oncogenes and ErbB2 is often overexpressed in many cancer types, in the present study we explored the link between ErbB2, Ras and nucleolin oncogenes. Using cell biology and biochemistry methods, we have demonstrated that NCL interaction with ErbB2 is enhanced by H-Ras (12 V) protein. The three proteins colocalize mainly at the plasma membrane, and in other intracellular sites. Using proximity ligation assay, we show that H-Ras (12 V) enhances the formation of ErbB2/NCL complexes, which reside mainly at the plasma membrane but may also be in the cytosol and nucleus. The interaction of the three oncogenes is associated with enhanced ErbB2 phosphorylation as well as ErbB2 mediated downstream signaling to Erk and Akt. Moreover, expression of the three proteins enhances colony formation, anchorage independent growth and cell migration. Thus, activated Ras can enhance the oncogenic effect of ErbB2 and NCL. These findings can be used to develop new ways to treat tumors that overexpress ErbB2/nucleolin and mutant Ras.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Tel-Aviv University, Ramat-Aviv 69978, Israel.
- Department of Neurobiology, Tel-Aviv University, Ramat-Aviv 69978, Israel. Electronic address: lironit@tauex.tau.ac.il.
Förderung
- Israel Cancer Association
Zitieren
APA
Zysman, G., Kochavi, A., Haklai, R., & Pinkas-Kramarski, R. (2026). Oncogenic crosstalk between ErbB2, nucleolin and Ras. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112427
Vancouver
Zysman G, Kochavi A, Haklai R, Pinkas-Kramarski R. Oncogenic crosstalk between ErbB2, nucleolin and Ras. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112427
BibTeX
@article{Zysman2026,
author = {Zysman, Gal and Kochavi, Adva and Haklai, Roni and Pinkas-Kramarski, Ronit},
title = {Oncogenic crosstalk between ErbB2, nucleolin and Ras},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112427}
}
EUVIMED